Daily FNArena News - Australia

Most brokers believe Orora has made the right decision to sell its Australasian fibre business to Nippon Paper, although this increases its exposure to North America.

While corporate travel and online growth underpin Flight Centre, the leisure business is mired in several uncertainties and profit is expected to decline in the first half.

Specialist fund platforms continue to benefit from disruption, taking business from the majors, but brokers point out a squeeze on cash accounts looms large amid further cuts to official interest rates.

As a record low cash rate prevails, amid weak consumer and business sentiment and only muted improvements in housing activity, Australia’s major banks are being squeezed mercilessly.

A new specialty female oral contraceptive will grace the portfolio of Mayne Pharma, providing a substantial growth opportunity in the medium-long term.

GUD Holdings has successfully coupled cost reductions with price rises and reiterates guidance for modest earnings growth in FY20.

Suncorp Group will sell two motor repair businesses to AMA Group, in a deal designed to improve utilisation of the repair shops while retaining a cost benefit.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

Nufarm has addressed a vulnerable capital position with the sale of its South American crop protection business and investors can now focus on fundamentals.

Fonterra Shareholders’ Fund is dealing with a raft of problems and brokers take a cautious stance until there is evidence of traction in the proposed solutions.